196 related articles for article (PubMed ID: 30676113)
1. Side effects associated with pharmacotherapy for pediatric irritable bowel syndrome and functional abdominal pain - not otherwise specified: a systematic review.
Rexwinkel R; Zeevenhooven J; van Etten-Jamaludin FS; Benninga MA; Tabbers MM
Expert Opin Drug Saf; 2019 Feb; 18(2):111-125. PubMed ID: 30676113
[TBL] [Abstract][Full Text] [Related]
2. Management of functional abdominal pain and irritable bowel syndrome in children and adolescents.
Chiou E; Nurko S
Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):293-304. PubMed ID: 20528117
[TBL] [Abstract][Full Text] [Related]
3. Lubiprostone Is Effective in the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Li F; Fu T; Tong WD; Liu BH; Li CX; Gao Y; Wu JS; Wang XF; Zhang AP
Mayo Clin Proc; 2016 Apr; 91(4):456-68. PubMed ID: 27046523
[TBL] [Abstract][Full Text] [Related]
4. Tegaserod for the treatment of irritable bowel syndrome.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
[TBL] [Abstract][Full Text] [Related]
5. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
[TBL] [Abstract][Full Text] [Related]
6. Parental Factors in Pediatric Functional Abdominal Pain Disorders: A Cross-sectional Cohort Study.
Zeevenhooven J; Rutten JMTM; van Dijk M; Peeters B; Benninga MA
J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):e20-e26. PubMed ID: 30289821
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review.
Browne PD; Nagelkerke SCJ; van Etten-Jamaludin FS; Benninga MA; Tabbers MM
Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1195-1208. PubMed ID: 30360666
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
Shah E; Kim S; Chong K; Lembo A; Pimentel M
Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104
[TBL] [Abstract][Full Text] [Related]
9. Cisapride for intestinal constipation.
Aboumarzouk OM; Agarwal T; Antakia R; Shariff U; Nelson RL
Cochrane Database Syst Rev; 2011 Jan; (1):CD007780. PubMed ID: 21249695
[TBL] [Abstract][Full Text] [Related]
10. Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review.
Mosińska P; Salaga M; Fichna J
Expert Opin Investig Drugs; 2016; 25(3):275-86. PubMed ID: 26765585
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery approaches to irritable bowel syndrome.
Hornby PJ
Expert Opin Drug Discov; 2015; 10(8):809-24. PubMed ID: 26193876
[TBL] [Abstract][Full Text] [Related]
12. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
14. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for pediatric irritable bowel syndrome.
Pesce M; Puoti MG; Rybak A; Andreozzi M; Bruzzese E; Sarnelli G; Borrelli O
Expert Opin Pharmacother; 2022 Jan; 23(1):91-103. PubMed ID: 34523358
[TBL] [Abstract][Full Text] [Related]
16. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
Johnston JM; Shiff SJ; Quigley EM
Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
[TBL] [Abstract][Full Text] [Related]
17. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
[TBL] [Abstract][Full Text] [Related]
18. Effects of linaclotide in patients with irritable bowel syndrome with constipation or chronic constipation: a meta-analysis.
Videlock EJ; Cheng V; Cremonini F
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1084-1092.e3; quiz e68. PubMed ID: 23644388
[TBL] [Abstract][Full Text] [Related]
19. Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review.
Rutten JM; Reitsma JB; Vlieger AM; Benninga MA
Arch Dis Child; 2013 Apr; 98(4):252-7. PubMed ID: 23220208
[TBL] [Abstract][Full Text] [Related]
20. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
Thomas RH; Luthin DR
Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
